| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
,
* Gene Therapy Program, University of Alabama, Birmingham, AL 35294;
Department of Medical Oncology,
Department of Pathology, and
Gene Therapy Program, Academic Hospital of the Free University, Amsterdam, The Netherlands; and
¶ Baylor Institute for Immunology Research, Baylor Research Institute, Dallas, TX 75246
Important therapeutic applications of genetically modified dendritic cells (DC) have been proposed; however, current vector systems have demonstrated only limited gene delivery efficacy to this cell type. By means of bispecific Abs, we have dramatically enhanced gene transfer to monocyte derived DC (MDDC) by retargeting adenoviral (Ad) vectors to a marker expressed on DC, CD40. Adenovirus targeted to CD40 demonstrated dramatic improvements in gene transfer relative to untargeted Ad vectors. Fundamental to the novelty of this system is the capacity of the vector itself to modulate the immunological status of the MDDC. This vector induces DC maturation as demonstrated phenotypically by increased expression of CD83, MHC, and costimulatory molecules, as well as functionally by production of IL-12 and an enhanced allostimulatory capacity in a MLR. In comparing this vector to other Ad-based gene transfer systems, we have illustrated that the features of DC maturation are not a function of the Ad particle, but rather a consequence of targeting to the CD40 marker. This vector approach may thus mediate not only high-efficiency gene delivery but also serve a proactive role in DC activation that could ultimately strengthen the utility of this vector for immunotherapy strategies.
This article has been cited by other articles:
|
|
 |
|
  S. Worgall, A. Krause, J. Qiu, J. Joh, N. R. Hackett, and R. G. Crystal Protective Immunity to Pseudomonas aeruginosa Induced with a Capsid-Modified Adenovirus Expressing P. aeruginosa OprF J. Virol., December 15, 2007; 81(24): 13801 - 13808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Bins, M. C. Wolkers, M. D. van den Boom, J. B. A. G. Haanen, and T. N. M. Schumacher In Vivo Antigen Stability Affects DNA Vaccine Immunogenicity J. Immunol., August 15, 2007; 179(4): 2126 - 2133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nociari, O. Ocheretina, J. W. Schoggins, and E. Falck-Pedersen Sensing Infection by Adenovirus: Toll-Like Receptor-Independent Viral DNA Recognition Signals Activation of the Interferon Regulatory Factor 3 Master Regulator J. Virol., April 15, 2007; 81(8): 4145 - 4157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. de Gruijl, O. J. A. E. Ophorst, J. Goudsmit, S. Verhaagh, S. M. Lougheed, K. Radosevic, M. J. E. Havenga, and R. J. Scheper Intradermal Delivery of Adenoviral Type-35 Vectors Leads to High Efficiency Transduction of Mature, CD8+ T Cell-Stimulating Skin-Emigrated Dendritic Cells J. Immunol., August 15, 2006; 177(4): 2208 - 2215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Krause, J. H. Joh, N. R. Hackett, P. W. Roelvink, J. T. Bruder, T. J. Wickham, I. Kovesdi, R. G. Crystal, and S. Worgall Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity. J. Virol., June 1, 2006; 80(11): 5523 - 5530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J.C.L.M. Vuylsteke, B. G. Molenkamp, P. A.M. van Leeuwen, S. Meijer, P. G.J.T.B. Wijnands, J. B.A.G. Haanen, R. J. Scheper, and T. D. de Gruijl Tumor-Specific CD8+ T Cell Reactivity in the Sentinel Lymph Node of GM-CSF-Treated Stage I Melanoma Patients is Associated with High Myeloid Dendritic Cell Content. Clin. Cancer Res., May 1, 2006; 12(9): 2826 - 2833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Shayakhmetov, A. M. Eberly, Z.-Y. Li, and A. Lieber Deletion of Penton RGD Motifs Affects the Efficiency of both the Internalization and the Endosome Escape of Viral Particles Containing Adenovirus Serotype 5 or 35 Fiber Knobs J. Virol., January 15, 2005; 79(2): 1053 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sakai, B. J. Morrison, J. D. Burke, J.-M. Park, M. Terabe, J. E. Janik, G. Forni, J. A. Berzofsky, and J. C. Morris Vaccination by Genetically Modified Dendritic Cells Expressing a Truncated neu Oncogene Prevents Development of Breast Cancer in Transgenic Mice Cancer Res., November 1, 2004; 64(21): 8022 - 8028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Shayakhmetov, Z.-Y. Li, A. Gaggar, H. Gharwan, V. Ternovoi, V. Sandig, and A. Lieber Genome Size and Structure Determine Efficiency of Postinternalization Steps and Gene Transfer of Capsid-Modified Adenovirus Vectors in a Cell-Type-Specific Manner J. Virol., September 15, 2004; 78(18): 10009 - 10022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Curiel, C. Morris, M. Brumlik, S. J. Landry, K. Finstad, A. Nelson, V. Joshi, C. Hawkins, X. Alarez, A. Lackner, et al. Peptides Identified through Phage Display Direct Immunogenic Antigen to Dendritic Cells J. Immunol., June 15, 2004; 172(12): 7425 - 7431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T. Mercier, J. A. Campbell, J. D. Chappell, T. Stehle, T. S. Dermody, and M. A. Barry A chimeric adenovirus vector encoding reovirus attachment protein {sigma}1 targets cells expressing junctional adhesion molecule 1 PNAS, April 20, 2004; 101(16): 6188 - 6193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Worgall, A. Busch, M. Rivara, D. Bonnyay, P. L. Leopold, R. Merritt, N. R. Hackett, P. W. Rovelink, J. T. Bruder, T. J. Wickham, et al. Modification to the Capsid of the Adenovirus Vector That Enhances Dendritic Cell Infection and Transgene-Specific Cellular Immune Responses J. Virol., March 1, 2004; 78(5): 2572 - 2580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Larregina, A. E. Morelli, O. Tkacheva, G. Erdos, C. Donahue, S. C. Watkins, A. W. Thomson, and L. D. Falo Jr Highly efficient expression of transgenic proteins by naked DNA-transfected dendritic cells through terminal differentiation Blood, February 1, 2004; 103(3): 811 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Korokhov, G. Mikheeva, A. Krendelshchikov, N. Belousova, V. Simonenko, V. Krendelshchikova, A. Pereboev, A. Kotov, O. Kotova, P. L. Triozzi, et al. Targeting of Adenovirus via Genetic Modification of the Viral Capsid Combined with a Protein Bridge J. Virol., December 15, 2003; 77(24): 12931 - 12940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Belousova, N. Korokhov, V. Krendelshchikova, V. Simonenko, G. Mikheeva, P. L. Triozzi, W. A. Aldrich, P. T. Banerjee, S. D. Gillies, D. T. Curiel, et al. Genetically Targeted Adenovirus Vector Directed to CD40-Expressing Cells J. Virol., November 1, 2003; 77(21): 11367 - 11377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Rux, P. R. Kuser, and R. M. Burnett Structural and Phylogenetic Analysis of Adenovirus Hexons by Use of High-Resolution X-Ray Crystallographic, Molecular Modeling, and Sequence-Based Methods J. Virol., September 1, 2003; 77(17): 9553 - 9566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. de Gruijl, S. A. Luykx-de Bakker, B. W. Tillman, A. J. M. van den Eertwegh, J. Buter, S. M. Lougheed, G. J. van der Bij, A. M. Safer, H. J. Haisma, D. T. Curiel, et al. Prolonged Maturation and Enhanced Transduction of Dendritic Cells Migrated from Human Skin Explants After In Situ Delivery of CD40-Targeted Adenoviral Vectors J. Immunol., November 1, 2002; 169(9): 5322 - 5331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Roth, Q. Cheng, A. Harui, S. K. Basak, K. Mitani, T. A. Low, and S. M. Kiertscher Helper-Dependent Adenoviral Vectors Efficiently Express Transgenes in Human Dendritic Cells but Still Stimulate Antiviral Immune Responses J. Immunol., October 15, 2002; 169(8): 4651 - 4656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Miller, S. Lahrs, V. G. Pillarisetty, A. B. Shah, and R. P. DeMatteo Adenovirus Infection Enhances Dendritic Cell Immunostimulatory Properties and Induces Natural Killer and T-Cell-mediated Tumor Protection Cancer Res., September 15, 2002; 62(18): 5260 - 5266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Bykovskaia, G. V. Shurin, S. Graner, M. L. Bunker, W. Olson, R. Thomas, M. R. Shurin, S. Marks, W. J. Storkus, and J. Shogan Differentiation of Immunostimulatory Stem-Cell- and Monocyte-Derived Dendritic Cells Involves Maturation of Intracellular Compartments Responsible for Antigen Presentation and Secretion Stem Cells, September 1, 2002; 20(5): 380 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Bontkes, T. D. de Gruijl, G. J. Schuurhuis, R. J. Scheper, C. J. L. M. Meijer, and E. Hooijberg Expansion of dendritic cell precursors from human CD34+ progenitor cells isolated from healthy donor blood; growth factor combination determines proliferation rate and functional outcome J. Leukoc. Biol., August 1, 2002; 72(2): 321 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. C. L. M. Vuylsteke, P. A. M. van Leeuwen, S. Meijer, P. G. J. T. B. Wijnands, M. G. Statius Muller, D. H. Busch, R. J. Scheper, and T. D. de Gruijl Sampling Tumor-Draining Lymph Nodes for Phenotypic and Functional Analysis of Dendritic Cells and T Cells Am. J. Pathol., July 1, 2002; 161(1): 19 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Masterson, C. C. Sombroek, T. D. de Gruijl, Y. M. F. Graus, H. J. J. van der Vliet, S. M. Lougheed, A. J. M. van den Eertwegh, H. M. Pinedo, and R. J. Scheper MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors Blood, June 28, 2002; 100(2): 701 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Sombroek, A. G. M. Stam, A. J. Masterson, S. M. Lougheed, M. J. A. G. Schakel, C. J. L. M. Meijer, H. M. Pinedo, A. J. M. van den Eertwegh, R. J. Scheper, and T. D. de Gruijl Prostanoids Play a Major Role in the Primary Tumor-Induced Inhibition of Dendritic Cell Differentiation J. Immunol., May 1, 2002; 168(9): 4333 - 4343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Lyakh, G. K. Koski, H. A. Young, S. E. Spence, P. A. Cohen, and N. R. Rice Adenovirus type 5 vectors induce dendritic cell differentiation in human CD14+ monocytes cultured under serum-free conditions Blood, January 15, 2002; 99(2): 600 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Okada, T. Saito, Y. Masunaga, Y. Tsukada, S. Nakagawa, H. Mizuguchi, K. Mori, Y. Okada, T. Fujita, T. Hayakawa, et al. Efficient Antigen Gene Transduction Using Arg-Gly-Asp Fiber-Mutant Adenovirus Vectors Can Potentiate Antitumor Vaccine Efficacy and Maturation of Murine Dendritic Cells Cancer Res., November 1, 2001; 61(21): 7913 - 7919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ponnazhagan, D. T. Curiel, D. R. Shaw, R. D. Alvarez, and G. P. Siegal Adeno-associated Virus for Cancer Gene Therapy Cancer Res., September 1, 2001; 61(17): 6313 - 6321. [Full Text] [PDF]
|
|
|
|
|
|
D. Rea, M. J. E. Havenga, M. van den Assem, R. P. M. Sutmuller, A. Lemckert, R. C. Hoeben, A. Bout, C. J. M. Melief, and R. Offringa Highly Efficient Transduction of Human Monocyte-Derived Dendritic Cells with Subgroup B Fiber-Modified Adenovirus Vectors Enhances Transgene-Encoded Antigen Presentation to Cytotoxic T Cells J. Immunol., April 15, 2001; 166(8): 5236 - 5244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Douglas, M. Kim, L. A. Sumerel, D. E. Carey, and D. T. Curiel Efficient Oncolysis by a Replicating Adenovirus (Ad) in Vivo Is Critically Dependent on Tumor Expression of Primary Ad Receptors Cancer Res., February 1, 2001; 61(3): 813 - 817. [Abstract] [Full Text]
|
|
|
|
|
|
C. Ebbinghaus, A. Al-Jaibaji, E. Operschall, A. Schöffel, I. Peter, U. F. Greber, and S. Hemmi Functional and Selective Targeting of Adenovirus to High-Affinity Fc{gamma} Receptor I-Positive Cells by Using a Bispecific Hybrid Adapter J. Virol., January 1, 2001; 75(1): 480 - 489. [Abstract] [Full Text]
|
|
|
|
|
|
V. Krasnykh, I. Dmitriev, J.-G. Navarro, N. Belousova, E. Kashentseva, J. Xiang, J. T. Douglas, and D. T. Curiel Advanced Generation Adenoviral Vectors Possess Augmented Gene Transfer Efficiency Based upon Coxsackie Adenovirus Receptor-independent Cellular Entry Capacity Cancer Res., December 1, 2000; 60(24): 6784 - 6787. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. C. Russell Update on adenovirus and its vectors J. Gen. Virol., November 1, 2000; 81(11): 2573 - 2604. [Full Text]
|
|
|
|
|
|
A. E. Morelli, A. T. Larregina, R. W. Ganster, A. F. Zahorchak, J. M. Plowey, T. Takayama, A. J. Logar, P. D. Robbins, L. D. Falo, and A. W. Thomson Recombinant Adenovirus Induces Maturation of Dendritic Cells via an NF-kappa B-Dependent Pathway J. Virol., October 15, 2000; 74(20): 9617 - 9628. [Abstract] [Full Text]
|
|
|
|
|
|
B. W. Tillman, T. L. Hayes, T. D. deGruijl, J. T. Douglas, and D. T. Curiel Adenoviral Vectors Targeted to CD40 Enhance the Efficacy of Dendritic Cell-based Vaccination against Human Papillomavirus 16-induced Tumor Cells in a Murine Model Cancer Res., October 1, 2000; 60(19): 5456 - 5463. [Abstract] [Full Text]
|
|
|
|
|
|
I. Dmitriev, E. Kashentseva, B. E. Rogers, V. Krasnykh, and D. T. Curiel Ectodomain of Coxsackievirus and Adenovirus Receptor Genetically Fused to Epidermal Growth Factor Mediates Adenovirus Targeting to Epidermal Growth Factor Receptor-Positive Cells J. Virol., August 1, 2000; 74(15): 6875 - 6884. [Abstract] [Full Text]
|
|
|
|
|
|
D. Rea, F. H. E. Schagen, R. C. Hoeben, M. Mehtali, M. J. E. Havenga, R. E. M. Toes, C. J. M. Melief, and R. Offringa Adenoviruses Activate Human Dendritic Cells without Polarization toward a T-Helper Type 1-Inducing Subset J. Virol., December 1, 1999; 73(12): 10245 - 10253. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
